Dr. Patrick Walsh Provides Important Web Content for PCF Website Visitors

	Johns Hopkins prostate cancer surgeon Dr. Patrick Walsh has made Chapter 2, "Little Gland, Big Trouble," of his book available online.
See Dr. Walsh's interview by PBS' Charlie Rose.

The Prostate Cancer Foundation Launches the PCF 100 Awards

"It's time for the next wave of brilliant young minds to make prostate cancer preventable or curable at any stage."

Jonathan W. Simons, MD
President and CEO
David H. Koch Chair

PCF's goal is to raise $22.5 million over the next five years to fund 100 Young Investigators.  Each investigator will be supported for three years. It's a win-win: the 100 best young investigators will receive funding from donors/sponsors matched by each institution — dollar for dollar. Read more about the PCF 100.

Purchase PCF Wristbands

Support PCF by shopping at the PCF Store for wristbands, cookbooks and other items.

Results Reported for New Antiandrogen (MDV3100) in Advanced Prostate Cancer

Dr. Howard Scher reports early results for clinical investigation of new antiandrogen (MDV3100) in advanced prostate cancer.

AACR-PCF Recognition Awards


The PCF invests in human capital through awards that recognize the top presentations at international cancer research meetings.  The inaugural AACR-Prostate Cancer Foundation Recognition Awards for Research Excellence have been announced.

PCF-Backed Researcher Wins AACR Award for Achievement in Cancer Research

With backing from the PCF, Arul Chinnaiyan, M.D., Ph.D. has discovered how 'fused' genes can turn on the switch that lead to prostate cancer. Dr. Chinnaiyan has won the 2008 American Association for Cancer Research Award for Outstanding Achievement in Cancer Research. 

Enthusiastic Response to PCF 2008 Challenge Awards


The 2008 PCF Challenge Awards launched a global response from prostate cancer researchers. Medical research centers from 11 countries and 6 continents submitted over 110 proposals. Nearly half (55) came from multi-institutional partnerships. Projects covered include biomarkers, gene fusion, androgen signaling, predictive models, nutrition, metabolism and survivorship, epigenetics, immunotheraphy, and stem cells.

The Case for Investing in a Cure for Prostate Cancer

PCF Board Member Elaine Wynn Honored at Milken Institute Global Conference